ArticleBioscience reports2018

Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus.

Xiaojing Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.